Redhill Biopharma
RDHL
$0.40
Share price
1.64%
Change (1 day)
-80.10%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Net assets
Net assets on the balance sheet as of June 2023 : $3.47 M
According to Redhill Biopharma's latest financial reports the company has $3.47 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Redhill Biopharma - Net assets on balance sheet (from 2011 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-48.4 M | -645.35% |
| 2021-12-31 | $8.87 M | -35.99% |
| 2020-12-31 | $13.86 M | -76.89% |
| 2019-12-31 | $60 M | 17.22% |
| 2018-12-31 | $51.18 M | 13.58% |
| 2017-12-31 | $45.06 M | -28.13% |
| 2016-12-31 | $62.7 M | 4.37% |
| 2015-12-31 | $60.07 M | 140.2% |
| 2014-12-31 | $25.01 M | 109.74% |
| 2013-12-31 | $11.92 M | -37.3% |
| 2012-12-31 | $19.01 M | 1.23% |
| 2011-12-31 | $18.78 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $82.20 B | 2,368,191.56% | 🇫🇷 France |
 Merck MRK | $40.42 B | 1,164,521.15% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.71 B | 481,542.18% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $7.54 B | 217,214.89% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $1.77 B | 51,155.83% | 🇮🇱 Israel |